OncoMed Pharmaceuticals Inc: cash_and_equivalents

Value{"amount": 8406000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"}
Period (as of 2018-09-30)
Statuscurrent
EntityOncoMed Pharmaceuticals Inc
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001564590-18-026250 · Open the official SEC filing →
Retrieved: 2026-08-19T12:24:59.902707+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001302573/cash-and-equivalents/2018-09-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/de27c570-9d20-493a-beea-a002e4e07d9a

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies